On #ClinicalTrialsDay, meet the next generation driving #CancerResearch forward. 👩🏻‍⚕️ In this video, Ioannis, Jens, and Antonella share what it means to be part of the EORTC Early Career Investigator community. Learn more: www.eortc.org/blog/2025/05... ▶️ youtu.be/cjPQDCxrZbI

Please have a look at our comment on #ICI and #TKI for unresectable #HCC published in @thelancetoncol.bsky.social @acammarota.bsky.social

"Science is a career for anyone curious enough to ask why, and stubborn enough to keep on asking." Yes, love this

Only a subset of patients respond to immunotherapy Why? Which ones? We conducted an unbiased analysis of response biomarkers and found that hundreds of possible biomarkers collapse into five latent, orthogonal factors that underlie immunotherapy response. www.nature.com/articles/s41...

Nice work from my (ex 😥) fellow @acammarota.bsky.social 👏👏 Examining PD-L1 expression in RCTs of chemo vs. chemo-ICI in operable GEA we show: ✅Strong link between PD-L1 and pathological response. ✖️ Less so OS .. www.esmogastro.org/article/S294... Looking forward to MATTERHORN next year!